Where you're treated first, matters. To make an appointment: 833-637-6698
Memorial Sloan Kettering Cancer Center
Loading...
Join MSK's Dr. Michael Morris at #ASCO26 as he presents results from CONVERGE-01 Part 3 evaluating Ac-225 rosopatamab tetraxetan in patients w/ metastatic castration-resistant #prostatecancer previously treated with Lu-PSMA therapy.
Learn more: meetings.asco.org/meetings/202...
MSK scientists have uncovered a hidden role for RNA.
Researchers led by MSK molecular and cell biologist @christinemayr.bsky.social found that RNA can act as a critical regulatory proteins, revealing a previously unknown function of RNA. Learn more: https://bit.ly/3QpBprx
🎉 Congrats to MSK's most recent awards & appointments, including Dr. Yelena Janjigian, Dr. Samuel Cytryn, and Dr. Jeremy Tchack for being awarded funding by the Torrey Coast Foundation; Dr. Scott Lowe for receiving the 2026 Lotus Award; and more: www.mskcc.org/news-release...
Join MSK thoracic medical oncologist Dr. Jamie Chaft at #ASCO26 as she presents results from the phase III ALCHEMIST trial evaluating nivolumab after surgery and adjuvant chemotherapy in patients with non-small cell lung cancer.
🕒 Monday, June 1 | 1:15 p.m. CDT
Learn more: https://bit.ly/3Q9i1Pw
Join MSK medical oncologist Dr. Darren Feldman at #ASCO26 for an education session on optimizing treatment for patients with poor-risk testicular cancer, including a discussion on the management of brain metastasis.
🕒 Monday, June 1 | 1:51 p.m. CDT
Learn more: https://bit.ly/4uEc3VN
Missed some of the research presented by MSK experts at #ASCO26?
We've rounded up selected highlights spanning sarcoma, liver cancer, lung cancer, prostate cancer, blood cancers, and more: https://bit.ly/3Qfyv8Q
Closing out strong, join MSK radiation oncologist Dr. Amy Xu at #ASCO26 as she presents results from a phase II study evaluating genomically personalized radiation dose de-escalation in patients with pathogenic ATM mutations.
🕒 Tuesday, June 2 | 10:39 a.m. CDT
Learn more: https://bit.ly/4x1m1ST
Coming up at #ASCO26: Join #melanoma medical oncologist Dr. Alexander Shoushtari for a presentation on how new tumor-infiltrating lymphocyte research can be translated into real benefit for patients. @mskcancercenter.bsky.social
🕒 Monday, June 1 | 5:30 p.m. CDT
Learn more: https://bit.ly/4nX5jjg
Memorial Sloan Kettering Cancer Center
📢 New Review Published in EXO!
Title: Ferroptosis spreading through propagative signals
By Drs. Saloni K. Hombalkar, Jyotirekha Das, and Michael Overholtzer from @mskcancercenter.bsky.social
🔗 Open access: sciexplor.com/exo/articles...
#Ferroptosis #CellDeath #RedoxBiology
Memorial Sloan Kettering Cancer Center
mRNA 3′ UTRs chaperone intrinsically disordered regions to control protein activity @cellcellpress.bsky.social @mskcancercenter.bsky.social @christinemayr.bsky.social
www.cell.com/cell/fulltex...
